Category: Uncategorized

QPS Holdings, a global contract research organization (CRO), has implemented the Oracle Argus pharmacovigilance system to enhance its safety case... Read more

Apiject Holdings Inc. has secured a 30,000-square-foot pharmaceutical site in Apex, North Carolina, to bolster domestic production of critical healthcare... Read more

Cytotheryx, a preclinical-stage cell therapy firm originating from the Mayo Clinic, has closed a $60 million Series A funding round.... Read more

During the 2026 J.P. Morgan Healthcare Conference, Novavax CEO John C. Jacobs outlined a transformative roadmap designed to evolve the... Read more

During the 44th Annual J.P. Morgan Healthcare Conference in January 2026, Enanta Pharmaceuticals detailed its strategic focus on developing oral... Read more

At the 44th Annual J.P. Morgan Healthcare Conference in January 2026, AbbVie presented a comprehensive update on its strategic evolution.... Read more

A collaborative open letter from Novartis and the Eurasia Group has called on world governments to address the growing "G-Zero"... Read more

Johnson & Johnson (J&J) has released positive top-line results from the phase 3 MajesTEC-9 trial, demonstrating the effectiveness of Tecvayli... Read more

Latest data from the Epcore DLBCL-1 clinical study indicates that Epkinly did not meet its primary endpoint of overall survival... Read more